New assays for Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6) expand menu to now 16 available CE-IVD assays Improved multiple-target assay for respiratory diseases in development; new dual-target SARS-CoV-2 design enables faster clinical decisions Multiplex assay for detection of monkeypox planned to be made available in 2022 HILDEN, Germany & GERMANTOWN, Md. — QIAGEN […]
ViQi, Inc, a California cloud-based image analysis company specializing in using artificial intelligence for the scientific discovery process, is excited to announce the appointment of Pascal Bamford, Ph.D. to the board of directors and Timothy Spicer, Ph.D. as the inaugural member of the scientific advisory board. SANTA BARBARA, Calif. – ViQi, Inc, a California cloud-based image analysis company specializing […]
Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfully completed extended concordance testing on Olink’s platforms (Olink® Target 48/96 and Olink® Explore), fulfilling specific requirements that supplement the Olink quality acceptance criteria. This latest validation was initiated by and implemented in cooperation with a leading global […]
ZEISS Lattice Lightsheet 7 enables the gentle 3D imaging of living cells Jena / Munich, Germany — Today, the Office of the Federal President announced the nominations for the German Future Prize (Deutscher Zukunftspreis) at the German Museum in Munich. ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen and Ralf Wolleschensky have been nominated for […]
Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN’s NGS testing portfolio for precision medicine beyond oncology into neurology applications HILDEN, Germany & GERMANTOWN Md. & SOUTH SAN FRANCISCO, Calif. — QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and Neuron23 Inc., an early stage […]
Cory Stevenson, former President of the BioProduction division at Thermo Fisher Scientific joins Board FORT LAUDERDALE, Fla and SACRAMENTO, Calif. — Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson to its Board of Directors. […]
Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it has invested in six genomics startups for the fifth global funding cycle of […]
INDIANAPOLIS and DUBLIN, IRELAND – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd. (“ValitaCell”), a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of […]
Highly customizable synthetic guide RNA (gRNA) libraries, coupled with established CRISPR expertise and support, enables researchers to quickly screen for new drug candidates CORALVILLE, Iowa — Bolstering its commitment to providing researchers with powerful tools to discover more about biology and advance medicine, global genomics solutions provider Integrated DNA Technologies (IDT) is expanding access to its customization […]
Dr. Sam Globus Joins Executive Team to Lead Scientific Team Curating the Human Genome ANN ARBOR, MICH. — Genomenon, Inc., an AI-driven genomics company, announced today that Dr. Sam Globus has been appointed vice president of operations. To support Genomenon’s goal to curate the entire human genome, Globus will manage the rapid growth of the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
